Left and right ventricular morphology and function in athletes with elevated pulmonary systolic arterial pressure

Echocardiography
O MireaC Militaru

Abstract

The objective of the study was to evaluate the prevalence and potential impact of elevated pulmonary arterial systolic pressure (PASP) on left and right cardiac morphology and function in young elite athletes. In total, 85 professional athletes (40 endurance, 20 strength, and 25 mixed training, mean age 17.8 ± 4.0) and 50 sedentary controls (mean age 18.6 ± 3.3) underwent transthoracic echocardiographic examination. Two-dimensional measurements of the right (RV) and left ventricle (LV) were obtained. PASP was estimated from the peak tricuspid regurgitant velocity (TRV). Speckle tracking-derived longitudinal LV and RV strain measurements (RV_LS) were calculated for function estimation. Maximum TRV (2.2 ± 0.3 vs 2.0 ± 0.2 m/s, P < .01) and PASP (26 ± 5 vs 22 ± 5 mm Hg, P < .01) were higher in athletes compared to controls. PAPS above 30 mm Hg (35 ± 3 mm Hg, range 31-40 mm Hg) was identified in 11 athletes (12.9%). Athletes with elevated PASP demonstrated higher LV mass (P < .01), LV stroke volume indexed (P < .01), larger RV-end-systolic area (ESAi), RV-end-diastolic area (EDAi), right atrium ES volume and ED volume, and decreased RV fractional area change (FAC) (P < .01) when compared to matched controls and higher RV-EDAi (13.0...Continue Reading

References

Jan 1, 1986·Journal of the American College of Cardiology·B J Maron
Jul 4, 1985·The New England Journal of Medicine·T P HustonW M Rodney
Apr 20, 2005·Journal of the American College of Cardiology·Barry J Maron, Douglas P Zipes
Mar 6, 2007·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Chad M BidartSteven J Lester
Jan 1, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Niek H PrakkenMaarten J Cramer
Sep 25, 2010·Chest·Antonello D'AndreaEduardo Bossone
Jul 9, 2011·International Journal of Cardiology·Antonello D'AndreaEduardo Bossone
Jul 22, 2011·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Yuko FukudaKen-Ichi Hirata
Dec 17, 2011·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·David OxboroughKeith George
Dec 24, 2011·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·André La GercheDavid L Prior
Jan 6, 2012·British Journal of Sports Medicine·Tim LuijkxBirgitta K Velthuis
Aug 18, 2012·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Antonello D'AndreaMaria Giovanna Russo
Oct 29, 2015·International Journal of Sports Medicine·G F GjerdalenK Steine
Feb 12, 2017·International Journal of Cardiology·Flavio D'AscenziSergio Mondillo
Oct 1, 2015·Journal of Cardiovascular Echography·Antonello D'AndreaMaria Giovanna Russo

❮ Previous
Next ❯

Citations

Jun 8, 2018·Echocardiography·Santhosh K G KoshyLekha K George
May 6, 2020·The International Journal of Cardiovascular Imaging·Antonello D'AndreaUNKNOWN Echocardiography Study Group of the Italian Society of Cardiology
May 18, 2021·Circulation. Cardiovascular Imaging·Tony G DawkinsMichael Stembridge
Oct 19, 2021·Frontiers in Cardiovascular Medicine·Pang-Yen LiuGen-Min Lin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.